from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0563/htpX

LFCtreatmentdescriptionclass of inhibitor

-0.386

Amikacinug/mL Amikacintranslation

-0.641

Cap5-10ug/mL Capreomycintranslation

-0.909

Rox10-50 ug/mL Roxithromycintranslation

-0.314

SM2-5 ug/mL Streptomycintranslation

-0.827

Tet5-10 ug/mL Tetracyclinetranslation

0.029

Rif0.2-5ug/mL Rifampicintranscription

0.834

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.744

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.152

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.529

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.443

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.369

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.133

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.647

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.109

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.468

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.459

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.417

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.351

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.205

Nigericin50 uM Nigericinrespiration

1.097

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-1.204

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.967

menadione6-10 ug/mL Menadionerespiration

-0.113

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.847

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.290

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.029

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.656

NRP_1Non-replicating persistence stage 1dosRassociated

-0.226

Amp0.2mg/mL AmpicillincellWall

-0.500

Cephalexin20-100 ug/mL CephalexincellWall

0.337

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.201

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.301

EMB10-20 ug/mL EthambutolcellWall

-0.926

Eta12-40 ug/mL EthionamidecellWall

-1.153

INH0.2-0.4 ug/mL IsoniazidcellWall

0.057

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.504

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.529

BZA0.12 mg/mL BenzamidearomaticAmides

0.909

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.727

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.211

H2O24 mM hydrogen peroxideDNAdamaging

0.006

Levo10 ug/mL LevofloxacinDNAdamaging

0.108

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.684

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.254

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.241

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.172

Antimycin12.5-50 ug/mL Antimycin A?

-1.027

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.266

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.456

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.171

PA8240.2-2 ug/mL PA-824?

0.591

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.204

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.474

Verapamil50 uM Verapamil?

-2.342

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.232

methoxatin10-20 ug/mL Methoxatin?